B.1.617.2 enters and fuses lung cells with increased efficiency

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…

Frontiers Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

Why SARS-CoV-2 delta variant is more infectious

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

Pharmaceuticals, Free Full-Text

PDF) No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study - eBioMedicine

Frontiers Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses - eBioMedicine

Full article: Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2

Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective

Messages from the COVID-19 Response Task Force

Updates on COVID-19 Variants – National Collaborating Centre for Infectious Diseases